Behind the Coronavirus Threat, a Middleman Destroying Prescription Drug Markets

Group purchasing organizations (GPOs) have driven many of the generic drug manufacturers out of business, and pushed those remaining to locate factories in China, ground zero for the epidemic.

by

The American Prospect is fiercely independent and reader-funded. Your support directly funds our team of investigative reporters, fact-checkers, and editors who produce in-depth journalism that holds the powerful accountable.

If you believe in reporting that informs, challenges, and inspires, there are two key ways to support us:


Donate to keep our nonprofit newsroom strong and fearless
Subscribe to our award-winning print magazine and receive our hard-hitting reporting and analysis in your mailbox 6 times a year

Your support makes our journalism possible. Thank you for standing with us.